InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Karas Eric. Officer active across 1 company, notably ARS Pharmaceuticals, Inc.. Aggregated, 8 disclosures have been published. Breakdown: 0 buy · 1 sell. History available since 19 August 2024. The latest transaction was filed on 1 July 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Karas Eric is Chief Commercial Officer at ARS Pharmaceuticals, Inc. He has filed 8 disclosures in total, and across the 8 sampled recent filings, the transactions run from 2024-08-21 to 2026-06-12, with buy volume of EUR 0 and sell volume of EUR 0. The most frequent transaction nature is Option exercise.